Bausch + Lomb makes progress on development of oral treatment for dry AMD

Summary

Bausch + Lomb announced progress on the development of an oral treatment candidate for dry age-related macular degeneration. Limited details are provided in the article regarding the specific drug, development stage, or clinical data.